Search results
AbbVie First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 5 days agoAbbVie (NYSE:ABBV) First Quarter 2024 Results Key Financial Results Revenue: US$12.3b (flat on 1Q...
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 7 days agoWhile the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed...
AbbVie (ABBV) Could Be a Great Choice
Zacks· 3 days agoCash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders ...
Q1 2024 AbbVie Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoParticipants Carrie C. Strom; Senior VP of AbbVie & President of Global Allergan Aesthetics; AbbVie Inc. Elizabeth Shea; SVP of IR; AbbVie</ ...
AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises
Morningstar· 7 days agoBy Dean Seal AbbVie raised its annual adjusted earnings guidance after revenue unexpectedly rose in the first quarter as lower sales of Humira were offset with gains elsewhere ...
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 7 days agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
AbbVie: Q1 Earnings Snapshot
Midland Reporter-Telegram· 7 days agoNORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday...
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 4 days agoOn Monday, Barclays made an adjustment to its outlook on AbbVie (NYSE:ABBV) shares, reducing the...
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 7 days agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
AbbVie tries to reassure investors on Humira biosimilar threat
BioPharma Dive via Yahoo Finance· 7 days agoDive Brief: U.S. Humira sales fell 40% year over year during the first three months of 2024, to...
